Approval: December 18, 2020

Now Approved for: Deficiency of IL-1 Receptor Antagonist (DIRA

Approval: December 1, 2020

Now Approved for: Nasal Polyps

Approval: December 18, 2020

Now Approved for: Chronic Sialorrhea in Patients Aged 2 Years and Older

Approval: December 16, 2020

Now Approved for: Adult Patients with Active Lupus Nephritis

Approval: December 18, 2020

Now Approved for: Adult Patients with Resistant or Intolerant Chronic-Phase CML

Approval: December 1, 2020

Now Approved for: Nighttime Sleep Disturbances in Smith-Magenis Syndrome

Approval: December 4, 2020

Now Approved for: Obesity in Adolescents Aged 12-17

Approval: December 20, 2020

Now Approved for: Early-Stage EGFR-Mutated Non-Small Cell Lung Cancer

Approval: December 14, 2020

Now Approved: Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple Sclerosis

Approval: December 14, 2020

Now Approved for: Patients with Multiple Myeloma After At Least One Prior Therapy

Approval: December 18, 2020

Now Approved for: Patients with Multiple Myeloma After At Least One Prior Therapy

Approval: December 1, 2020

Now Approved for: RET-Mutant and RET Fusion-Positive Thyroid Cancers

December 12, 2020

Anagrelide Capsules

Possible Side Effects: Increases the chance of a blood clot

Thrombocythemia

12/2021

October 27, 2020

GUM Paroex Chlorhexidine Gluconate Oral Rinse

Possible Side Effects: oral and, potentially, systemic infections requiring antibacterial therapy. In the most at-risk populations, the use of the defective product may result in life-threatening infections, such as pneumonia and bacteremia.

Gingivitis

N/A

January 5, 2020

100-count bottles of 750 mg Metformin HCl Extended Release Tablets

Possible Side Effects: Carcinogenic

Diabetes

07/2022